IGM Biosciences IncNASDAQ:IGMS
- LAST PRICE6.6500
- TODAY'S CHANGE (%)-0.3500 (-5.0000%)
- Bid / Lots4.3000/ 1
- Ask / Lots6.9800/ 4
- Open / Previous Close7.0000 / 7.0000
- Day Range
- 52 Week Range
- Volume390,330
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | IGMS |
|---|---|---|
| 09:32 ET | 4338 | 7.09 |
| 09:33 ET | 200 | 6.91 |
| 09:35 ET | 200 | 6.93 |
| 09:37 ET | 100 | 6.89 |
| 09:39 ET | 401 | 6.93 |
| 09:42 ET | 200 | 6.95 |
| 09:46 ET | 905 | 6.855 |
| 09:48 ET | 5189 | 6.82 |
| 09:50 ET | 9127 | 6.85 |
| 09:51 ET | 6193 | 6.84 |
| 09:53 ET | 2200 | 6.815 |
| 09:55 ET | 372 | 6.8 |
| 09:57 ET | 200 | 6.8 |
| 10:00 ET | 600 | 6.81 |
| 10:02 ET | 15183 | 6.85 |
| 10:04 ET | 1200 | 6.9 |
| 10:06 ET | 21786 | 6.94 |
| 10:08 ET | 4900 | 7 |
| 10:09 ET | 106 | 6.985 |
| 10:11 ET | 1100 | 6.98 |
| 10:13 ET | 3000 | 7.005 |
| 10:15 ET | 2898 | 7.04 |
| 10:18 ET | 974 | 7.01 |
| 10:20 ET | 100 | 7.035 |
| 10:22 ET | 320 | 7.0975 |
| 10:24 ET | 485 | 7.05 |
| 10:26 ET | 100 | 7.02 |
| 10:27 ET | 300 | 7.055 |
| 10:29 ET | 320 | 7.05 |
| 10:31 ET | 1383 | 7.02 |
| 10:36 ET | 541 | 6.99 |
| 10:38 ET | 500 | 6.98 |
| 10:40 ET | 400 | 6.985 |
| 10:42 ET | 250 | 6.9854 |
| 10:44 ET | 6644 | 7 |
| 10:45 ET | 220 | 7.02 |
| 10:49 ET | 500 | 7.0953 |
| 10:51 ET | 2696 | 7.065 |
| 10:56 ET | 800 | 7.07 |
| 11:00 ET | 100 | 7.05 |
| 11:05 ET | 716 | 7.06 |
| 11:09 ET | 200 | 7.03 |
| 11:12 ET | 2770 | 7.05 |
| 11:14 ET | 1232 | 7 |
| 11:16 ET | 3540 | 7 |
| 11:18 ET | 7074 | 6.95 |
| 11:20 ET | 3938 | 6.92 |
| 11:21 ET | 3414 | 6.96 |
| 11:23 ET | 2050 | 6.98 |
| 11:27 ET | 5390 | 6.98 |
| 11:30 ET | 5549 | 6.97 |
| 11:32 ET | 1826 | 7 |
| 11:36 ET | 843 | 6.96 |
| 11:38 ET | 8780 | 6.96 |
| 11:39 ET | 6359 | 6.915 |
| 11:41 ET | 2500 | 6.9 |
| 11:43 ET | 3102 | 6.9 |
| 11:45 ET | 8832 | 6.895 |
| 11:48 ET | 400 | 6.895 |
| 11:50 ET | 4431 | 6.84 |
| 11:52 ET | 1120 | 6.84 |
| 11:54 ET | 100 | 6.815 |
| 11:56 ET | 2800 | 6.82 |
| 11:57 ET | 12245 | 6.93 |
| 11:59 ET | 5356 | 6.98 |
| 12:01 ET | 100 | 6.955 |
| 12:06 ET | 200 | 6.93 |
| 12:08 ET | 100 | 6.975 |
| 12:14 ET | 100 | 6.93 |
| 12:15 ET | 600 | 6.87 |
| 12:19 ET | 200 | 6.85 |
| 12:24 ET | 100 | 6.81 |
| 12:26 ET | 443 | 6.8 |
| 12:30 ET | 200 | 6.79 |
| 12:32 ET | 100 | 6.78 |
| 12:33 ET | 522 | 6.77 |
| 12:35 ET | 100 | 6.74 |
| 12:37 ET | 100 | 6.74 |
| 12:42 ET | 100 | 6.78 |
| 12:44 ET | 2493 | 6.8 |
| 12:48 ET | 100 | 6.82 |
| 12:50 ET | 700 | 6.79 |
| 12:53 ET | 500 | 6.77 |
| 12:55 ET | 199 | 6.73 |
| 12:57 ET | 2000 | 6.79 |
| 01:02 ET | 600 | 6.84 |
| 01:04 ET | 100 | 6.845 |
| 01:06 ET | 300 | 6.83 |
| 01:08 ET | 800 | 6.7891 |
| 01:09 ET | 2031 | 6.72 |
| 01:11 ET | 100 | 6.75 |
| 01:18 ET | 100 | 6.71 |
| 01:20 ET | 100 | 6.71 |
| 01:24 ET | 1180 | 6.78 |
| 01:26 ET | 500 | 6.74 |
| 01:31 ET | 1935 | 6.6324 |
| 01:33 ET | 100 | 6.6411 |
| 01:40 ET | 644 | 6.62 |
| 01:42 ET | 100 | 6.645 |
| 01:49 ET | 620 | 6.57 |
| 01:56 ET | 100 | 6.58 |
| 02:03 ET | 2231 | 6.54 |
| 02:09 ET | 100 | 6.555 |
| 02:16 ET | 1172 | 6.55 |
| 02:18 ET | 942 | 6.5 |
| 02:21 ET | 1700 | 6.5327 |
| 02:23 ET | 4538 | 6.505 |
| 02:25 ET | 3904 | 6.45 |
| 02:30 ET | 3523 | 6.52 |
| 02:34 ET | 100 | 6.53 |
| 02:36 ET | 597 | 6.51 |
| 02:38 ET | 400 | 6.52 |
| 02:39 ET | 1107 | 6.525 |
| 02:41 ET | 300 | 6.525 |
| 02:45 ET | 400 | 6.545 |
| 02:48 ET | 1316 | 6.575 |
| 02:50 ET | 1000 | 6.5976 |
| 02:52 ET | 1109 | 6.6 |
| 02:57 ET | 100 | 6.615 |
| 03:01 ET | 729 | 6.625 |
| 03:03 ET | 6205 | 6.68 |
| 03:06 ET | 731 | 6.6876 |
| 03:08 ET | 1296 | 6.675 |
| 03:10 ET | 740 | 6.68 |
| 03:12 ET | 300 | 6.63 |
| 03:15 ET | 100 | 6.61 |
| 03:17 ET | 200 | 6.61 |
| 03:19 ET | 200 | 6.62 |
| 03:21 ET | 100 | 6.56 |
| 03:24 ET | 100 | 6.5 |
| 03:26 ET | 495 | 6.5377 |
| 03:28 ET | 2222 | 6.52 |
| 03:30 ET | 1400 | 6.564 |
| 03:32 ET | 100 | 6.59 |
| 03:33 ET | 300 | 6.56 |
| 03:35 ET | 1403 | 6.6 |
| 03:37 ET | 1700 | 6.57 |
| 03:39 ET | 618 | 6.56 |
| 03:42 ET | 2000 | 6.51 |
| 03:44 ET | 200 | 6.51 |
| 03:46 ET | 100 | 6.51 |
| 03:48 ET | 1802 | 6.47 |
| 03:50 ET | 1167 | 6.43 |
| 03:51 ET | 3023 | 6.51 |
| 03:53 ET | 1700 | 6.55 |
| 03:55 ET | 700 | 6.55 |
| 03:57 ET | 23309 | 6.6 |
| 04:00 ET | 36595 | 6.65 |
Dec 7, 2023
DJ IGM Biosciences Cut to Neutral From Buy by HC Wainwright & Co., from 11:19AM ET on Thursday Dec 07, 2023 by Dow Jones
11:19AM ET on Thursday Dec 07, 2023 by Dow Jones
Dec 6, 2023
DJ IGM Biosciences Is Maintained at Sector Perform by RBC Capital, from 11:00AM ET on Wednesday Dec 06, 2023 by Dow Jones
11:00AM ET on Wednesday Dec 06, 2023 by Dow JonesPress Release: Medivir's partner IGM Biosciences announces strategic pipeline prioritization to extend its cash runway, from 6:21AM ET on Wednesday Dec 06, 2023 by Dow Jones
6:21AM ET on Wednesday Dec 06, 2023 by Dow Jones
Dec 5, 2023
DJ Stocks to Watch: SentinelOne, MongoDB, IGM Biosciences, from 6:45PM ET on Tuesday Dec 05, 2023 by Dow Jones
6:45PM ET on Tuesday Dec 05, 2023 by Dow JonesDJ IGM Biosciences to Reduce Workforce by 22% Amid Broader Restructuring, from 4:28PM ET on Tuesday Dec 05, 2023 by Dow Jones
4:28PM ET on Tuesday Dec 05, 2023 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
IGM Biosciences Inc | 388.3M | -1.3x | --- |
Nautilus Biotechnology Inc | 379.9M | -6.3x | --- |
Tourmaline Bio Inc | 378.7M | -1.2x | --- |
Compass Pathways PLC | 400.5M | -2.5x | --- |
Third Harmonic Bio Inc | 401.6M | -9.4x | --- |
Conduit Pharmaceuticals Inc | 375.0M | -1,666.7x | --- |
Company Information
IGM Biosciences, Inc. is a clinical-stage biotechnology company focused on creating and developing engineered IgM antibodies for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. The Company has created an IgM antibody technology platform for developing T cell engagers, receptor cross-linking agonists, targeted cytokines and target neutralizers. Its product candidates in clinical testing include IGM-2323 and IGM-8444. IGM-2323 is a bispecific T cell engaging IgM antibody targeting CD20 and CD3 proteins, is in a Phase II clinical trial for the treatment of relapsed/refractory B cell non-Hodgkins lymphoma (NHL) patients. IGM-8444 is an IgM antibody targeting Death Receptor 5 (DR5) proteins for the treatment of patients with solid and hematologic malignancies, is in a Phase I clinical trial for the treatment of solid cancers. Its oncology pipeline also includes IGM-7354, IGM-2644 and IGM-2537.
Contact Information
- Headquarters
- 325 E Middlefield RdMOUNTAIN VIEW, CA, United States 94043-4003
- Phone
- 650-965-7873
- Fax
- 302-655-5049
Executives
- President, Chief Executive Officer, Director
- Fred Schwarzer
- Chief Financial Officer
- Misbah Tahir
- Chief Scientific Officer
- Bruce Keyt
- Chief Business Officer
- Lisa Decker
- Chief Commercial Officer
- George Gauthier
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $388.3M |
|---|---|
Revenue (TTM) | $1.9M |
Shares Outstanding | 58.4M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.19 |
EPS | $-4.99 |
Book Value | $6.67 |
P/E Ratio | -1.3x |
Price/Sales (TTM) | 209.8 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -13,755.05% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
